Molecure S.A.
MOC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 3,005 | PLN 0 | PLN 0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | PLN 0 | PLN 321 | PLN 686 | PLN 1,111 |
| Gross Profit | PLN 0 | PLN 2,685 | -PLN 686 | -PLN 1,111 |
| % Margin | – | 89.3% | – | – |
| R&D Expenses | PLN 371 | PLN 108 | PLN 0 | PLN 835 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| SG&A Expenses | PLN 4,470 | PLN 5,514 | PLN 0 | PLN 10,460 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 106 | PLN 818 | PLN 4,862 | -PLN 1,788 |
| Operating Expenses | PLN 4,735 | PLN 6,441 | PLN 4,862 | PLN 9,506 |
| Operating Income | -PLN 5,481 | -PLN 3,756 | -PLN 5,548 | -PLN 10,617 |
| % Margin | – | -125% | – | – |
| Other Income/Exp. Net | PLN 214 | PLN 246 | PLN 364 | PLN 158 |
| Pre-Tax Income | -PLN 5,266 | -PLN 3,510 | -PLN 5,185 | -PLN 10,458 |
| Tax Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Net Income | -PLN 5,266 | -PLN 3,510 | -PLN 5,185 | -PLN 10,458 |
| % Margin | – | -116.8% | – | – |
| EPS | -0.26 | -0.17 | -0.26 | -0.52 |
| % Growth | -52.9% | 34.6% | 50% | – |
| EPS Diluted | -0.26 | -0.17 | -0.26 | -0.52 |
| Weighted Avg Shares Out | 20,603 | 21,199 | 20,203 | 20,203 |
| Weighted Avg Shares Out Dil | 20,603 | 21,199 | 20,203 | 20,203 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 212 | PLN 200 | PLN 399 | PLN 152 |
| Interest Expense | PLN 20 | PLN 15 | PLN 5 | PLN 7 |
| Depreciation & Amortization | PLN 745 | PLN 1,352 | PLN 778 | PLN 954 |
| EBITDA | -PLN 4,501 | -PLN 2,405 | -PLN 4,407 | -PLN 9,505 |
| % Margin | – | -80% | – | – |